1. Physangulidine A, a withanolide from Physalis angulata, perturbs the cell cycle and induces cell death by apoptosis in prostate cancer cells.
- Author
-
Reyes-Reyes EM, Jin Z, Vaisberg AJ, Hammond GB, and Bates PJ
- Subjects
- Antineoplastic Agents chemistry, Apoptosis drug effects, Cell Cycle drug effects, Cell Division drug effects, Drug Screening Assays, Antitumor, G2 Phase drug effects, Humans, Male, Microscopy, Confocal, Molecular Structure, Prostatic Neoplasms drug therapy, Withanolides chemistry, Antineoplastic Agents isolation & purification, Antineoplastic Agents pharmacology, Physalis chemistry, Withanolides isolation & purification, Withanolides pharmacology
- Abstract
Recently, our group reported the discovery of three new withanolides, physangulidines A-C, from Physalis angulata. In this study, the biological effects of physangulidine A (1), which was the most active and abundant of the three new constituents, are described. It was found that 1 significantly reduces survival in clonogenic assays for two hormone-independent prostate cancer cell lines. Flow cytometry and confocal microscopy studies in DU145 human prostate cancer cells indicated that 1 induces cell cycle arrest in the G(2)/M phase and causes defective mitosis. It was determined also that 1 produces programed cell death by apoptosis, as evidenced by biochemical markers and distinct changes in cell morphology. These results imply that the antimitotic and proapoptotic effects of 1 may contribute significantly to the biological activities and potential medicinal properties of its plant of origin.
- Published
- 2013
- Full Text
- View/download PDF